Introduction
Risk management and examining ways to learn from adverse incidents have increased. This can be attributed in part to the Department of Health's (DH) publication An Organisation with a Memory (DH 2000) and, more recently, in England and Wales, to the National Patient Safety Agency (NPSA), which was established in 2001. The document An Organisation with a Memory acknowledges that adverse events occur in around 10 per cent of admissions and that service failures can have serious consequences for patients.
IV therapy presents a potential risk to patient safety, with associated risks varying from minor complications to death. The number of patients who require IV therapy is increasing, because more patients are acutely ill and also because of changes in prescribing patterns. To reduce risks associated with peripheral IV therapy, the risks need to be identified and managed.
The 'Swiss Cheese Model' of risk (Reason 2000) shows how, despite policies and procedures being in place, systems errors can still occur often with catastrophic results. Adverse incidents are typically caused by alignment of different factors; however, good practice can prevent errors becoming incidents (Amoore and Ingram 2002) . It is important that different aspects of peripheral IV therapy are considered, taking into account policy and practice, to reduce errors in clinical practice. This article identifies these aspects and offers recommendations for practice, with the aim of reducing the associated risks.
Many environmental hazards relate to storage, ventilation, lighting, space and professional and safety aspects, such as preparation time and support. For example, a busy and cramped treatment area could lead to needlestick injury. To their practice area and medicines.
Robust policies and procedures should be in place to help support and assess staff in clinical practice.
Staff must complete an approved competencybased training programme relating to their field of practice and be familiar with associated medicines and policies (Royal College of Nursing (RCN) 2003).
Up-to-date information should be readily available to support good practice (LUHD 2003b) , as well as expert resources, for example, a 24-hour pharmacy helpline.
CRAG (2003) stipulates that staff who undertake peripheral IV medicine administration must be subject to regular re-assessment of competence. NHS Education for Scotland (NES 2004 ) is developing a framework for transferability of clinical skills. NES (2004) suggests that the process of transferring clinical skills is driven by personal development plans and is subject to an annual appraisal.
Environment
The preparation of injections in clinical areas is associated with risks of contamination. CRAG (2003) recommends that staff undertake a risk assessment of the environment and the procedure. Staff should consider where medicines are prepared and query whether the following are in place:
Adequate lighting so the prescription can be read easily.
Adequate ventilation to reduce air contamination.
Enough space to prepare the injection safely.
A safe sharps' disposal system. Ability to work uninterrupted or free from distraction.
Staff should acknowledge and recognise the risk of medicine spillage, and protect themselves by ensuring safe reconstitution practice and medicine handling, and follow appropriate guidance on managing spillage (DH 2002) . One aspect that staff need to consider is the high risk of aerosol spray during the reconstitution of powdered medicines. Many medicines, particularly antibiotics, are in powder form and therefore require reconstitution before use. However, if the aerosol is sprayed into the atmosphere staff members may be exposed to that drug, which can be absorbed through mucous membranes. The use of a practical workstation allows staff to practise ensure good practice, the Clinical Resource and Audit Group (CRAG 2003) recommends regular planned audits of personnel, environment and procedures where there is preparation of injections in near-patient areas. The CRAG headings are used to review these aspects.
Personnel
NHS Lothian -University Hospitals Division (LUHD), through its Shared Governance Framework (LUHD 2002a), requires any registered nurse undertaking peripheral IV therapy to self-assess his or her competence every three months. This ensures the maintenance of skills and addresses any limitations related to professional accountability (Nursing and Midwifery Council (NMC) 2004a).
One of the risks associated with the peripheral IV route, as with other routes, is calculation of medicine doses. This requires educational support to enable staff competence (Hutton 1998 , LUHD 2003a . NMC (2004b) guidance on the administration of medicines specifies that two staff members are required where there are complex calculations, and that both practitioners need to calculate independently. Upton (2001) states that two registered practitioners are required throughout the IV drug administration procedure to participate in calculating, checking the prescription, selecting, dispensing, preparing, and administering the medicine as well as recording the procedure. This minimises the risk of medicine calculation or practice error. However, some organisations may consider single nurse administration acceptable.
Research suggests that common errors in drug administration include poor handwriting of prescriptions, staff failing to follow policy and poor communication (Cooper 1995 , Williams 1996 , Upton 2001 . However, an ethnographic study that specifically explored peripheral IV drug administration found that errors were most common during bolus administration and when making up medicines that required multiple-step preparation (Taxis and Barber 2003 
Procedures
The purpose of setting standards is clear: to inform and educate staff about current best evidence and practice. Peripheral IV therapy theory should relate to local and/or national guidance or procedures. NES (2004) is focusing on educational and training standards in clinical skills, venepuncture, cannulation and peripheral IV therapy. Such standards ensure that staff are trained to an appropriate level, now and for future approved levels, and staff can transfer skills without the need to repeat training.
The NMC Code of Professional Conduct states that each registered nurse has a responsibility to deliver care based on current evidence, best practice and, when available, validated research (NMC 2004a ). Policies and procedures should be documented and developed by experienced practitioners to reflect current issues in clinically effective care, and should be subject to annual review. Route There are three peripheral IV routes: bolus injection, intermittent and continuous infusion, and each have inherent risks. The rationale for route choice is based on knowledge of the medicine and its therapeutic effect. The patient, circumstances and equipment need to be considered. Peripheral route choice requires competent practice and effective clinical judgement to reduce risk and ensure safe practice (NMC 2004a) ( Table 1) .
When considering the peripheral IV route, administration factors such as compliance, absorption and rate of medicine administration are also important. Compliance The peripheral IV route ensures the prescribed medicine concentration is achieved rapidly. It overcomes any nil-by-mouth or fasting requirements, and may also overcome a patient's refusal to take oral medication. Absorption One hundred per cent bioavailability is achieved as the medicine is administered directly into the circulation and avoids the need for absorption; problems with malabsorption or medicine inactivation by the gut are also avoided. The risk of pain is also avoided; some medicines can be painful to the tissues and therefore cannot be given by the subcutaneous or intramuscular route (Dougherty and Lamb 1999 The benefits of the peripheral IV route outweigh the risks (CRAG 2003) ; however, this method requires registered medical and nursing staff to monitor the patient and the prescription regularly to ensure that the treatment continues to be the most appropriate and effective.
Infection
Infections resulting from peripheral IV therapy can cover a wide spectrum of clinical symptoms, from minor irritation to increased morbidity and mortality. Thus, the patient can experience minor irritation at the site (local infection), bacteraemia (bacteria are present in the blood) or more serious septicaemia (systemic infection). Box 1 shows the signs of local and systemic infection. Infection control should be an integral part of patient care. All nurses involved in peripheral IV therapy have a role to play in the prevention and containment of infection.
Infection can be divided into two groups: exogenous and endogenous. Exogenous infection occurs when micro-organisms originate outside the patient's body. This is usually due to crossinfection, for example, via the hands of healthcare professionals and equipment. Endogenous infection is due to organisms already present on or in the patient's body.
Exogenous and endogenous infection can be due to intrinsic and extrinsic contamination. Intrinsic contamination refers to infection that is present in the apparatus or medicine before use, whereas extrinsic is introduced during use. Table 3 shows intrinsic and extrinsic infection in relation to the different types of apparatus. Intrinsic and extrinsic infection Once intrinsic or extrinsic infection has been identified, it is essential that strategies are developed to reduce risk. The risk of infection by the intrinsic route can be greatly infusions are factors to be considered, taking into account time, cost and increased risk of infection. Risks associated with the peripheral IV route are summarised in Table 2 reduced by nurses' checking the packaging of all equipment for signs of contamination. Storing products in the correct environment and checking expiry dates also reduce the risk of infection. Checking that products are only for single use and are being used according to manufacturers' instructions is also essential. Extrinsic infection can be reduced by good handwashing and aseptic techniques, and by reviewing practice every time manipulation of the IV system is required. This includes changing the fluid and the infusion set and the use of three-way taps. Steps should be taken to minimise the number of manipulations and to ensure that good technique is used when doing so (Plumer and Weinstein 2001) .
It is essential that nurses seek ways to reduce the risk of infection for patients, while taking precautions to protect themselves. The most common types of catheter-associated infections are shown in Table 4 (LUHD 2003a) .
When diagnosing catheter-associated infections, microbiology results from the catheter and blood results should be considered in conjunction with the clinical presentation of the patient. Despite coagulase-negative staphylococci being the most common organism isolated from cultures, they do not cause bacteraemia as often as Staphylococcus aureus. Catheter-associated bacteraemia is associated with 22 per cent of patients with complications, such as endocarditis and osteomyelitis (LUHD 2003a) .
Infection control is the concern and responsibility of all healthcare staff. The implications of not identifying and containing infection can be detrimental to patient care. Patients may experience physical discomfort which may lead them to seek financial compensation. In addition, there are the increased costs of treating infection with antibiotic therapy and longer hospital stay. Recommendations for practice:
Consider whether a cannula is necessary. This is because some cannulae can be inserted 'routinely' and this practice should be challenged (Waitt et al 2004) . Use a polyurethane cannula where possible, as this is the best method of reducing phlebitis rates (Gaukroger et al 1988) .
Ensure appropriate cleaning products are used on the skin before insertion of the cannula: chlorhexidine 2% has been shown to reduce the rate of infection (Maki et al 1991) .
Cover the cannula with a transparent, semipermeable dressing. This allows the site to be viewed easily (Parker 1999 Use an aseptic technique for cannulation and all further manipulations of the IV system to reduce infection (Wilson 2001) .
TABLE 3 TABLE 4
Apart from medicines, other causative factors of anaphylaxis include food, stings and idiopathic causes. The International Liaison Committee on Resuscitation (ILCOR) (1997) noted the incidence of anaphylaxis at the time in the UK was around one in 2,300. However, due to unpredictability, actual numbers are not known (Henderson 1998) . Drain and Volcheck (2001) noted that with the increasing use of medicines and antibacterials in the United States, medicineinduced anaphylaxis and anaphylactoid reactions have increased. CRAG (2003) estimated the scale of anaphylaxis in NHS Scotland of near-patient antibiotic preparation at around 650,000 injections and a further 350,000 prepared in pharmacy. Therefore, it could be estimated that 435 reported cases of anaphylaxis a year are due to antibacterial agents alone, based on the premise of one in 2,300 and a total population of 1,000,000. Drain and Volcheck (2001) studied other causative agents, including non-steroidal anti-inflammatory drugs, anaesthetics, muscle relaxants, latex and radio-contrast media. Anaphylaxis is often unpredictable and so health professionals need to focus on how they can decrease the risks (Box 2).
Drain and Volcheck (2001) noted that the greater the number of years since the last administration of the offending agent, the less chance there is of a recurrence. Using the parenteral route for medication administration increases the severity and frequency of a reaction, so choice of medicine and route need to be reviewed regularly. If the patient still requires a peripheral IV route, he or she needs to remain under medical supervision for 20-30 minutes after medicine administration (LUHD 2004).
Immediate actions following anaphylaxis depend on the severity of the reaction. These can range from a mild skin reaction to cardiovascular collapse. Recommendations for practice:
Discontinue the suspected medicine.
Administer oxygen, adrenaline (epinephrine) and IV fluids.
Get help, activate the emergency help button Avoid lower extremities, joints and nerves when siting the cannula. Lower extremities are more difficult to view. Cannulating over joints is uncomfortable, reduces patient mobility and, if nerves are damaged, may cause patient harm.
Try to reduce the number of attempts to cannulate, as increased puncture sites means increased entry sites for infection.
Identify patients at risk and take additional precautions, including those who are older or younger, those who already have an infection, are immunosuppressed, have poor nutrition, have a loss of skin integrity, are on antibiotic therapy and patients having multiple invasive procedures (Dougherty 2002).
Record and report any signs of infection (NMC 2004c).
Educate staff in the portals for entry of infection so that steps can be taken to reduce risks.
Clean infusion equipment before and after use. Check whether equipment is for single use only. Equipment such as drip stands and infusion equipment can be contaminated, therefore it needs to be cleaned regularly and between patients (Medical Devices Agency 1996).
Good hand washing techniques and precautions to protect staff should always be employed. Contaminated hands of staff is a major source of infection. Gloves, aprons and, if necessary, masks and goggles should be worn if staff administering peripheral IV therapy are at risk (RCN 2003) . CRAG (2003) reported that no therapeutic intervention is risk-free, but that the benefits of the medicine outweigh the risks. One key risk related to peripheral IV therapy management is anaphylaxis (Henderson 1998 , Drain and Volcheck 2001 , LUHD 2004 (NMC 2004c) , and consideration of the Yellow Card Scheme. The Yellow Card Scheme promotes the reporting of adverse medicine reactions, in this situation (anaphylaxis) type B; described as 'a novel response not expected from the known pharmacological actions of the medicine' (Committee on Safety of Medicines and Medicines Control Agency 2002). The patient will require advice on safety issues for the future. This might include the use of a Medic Alert, a bracelet identification system, or an adrenaline (epinephrine) kit. Speedshock An associated hazard with peripheral IV therapy is speedshock, described by Dougherty and Lamb (1999) and Plumer and Weinstein (2001) as a systemic reaction that occurs when a substance that is foreign to the body is rapidly introduced. This occurs most commonly with rapid bolus injection, and is one reason why LUHD developed The Preparation and Administration of Parenteral Medicines policy (LUHD 2003b) to ensure safe and consistent practice. The document includes recommended rates of medicine administration and flush volume and rate: flush rate should be no faster than the medicine that has been administered. Plumer and Weinstein (2001) recommend the use of a medical device to regulate flow. Flushing guidance is often overlooked, but is an essential component of peripheral IV care. The flush volume should be equal to at least twice the volume of the catheter, usually 5-10ml of 0.9% sodium chloride (RCN 2003) .
Phlebitis,infiltration and extravasation
It is important to consider the route, speed and effects on the venous system and tissues when infusing substances intravenously. Pain at the insertion site can be due to phlebitis, infiltration or extravasation. To identify and manage these risks, it is essential to differentiate between the different terms that relate to different types of injury. Phlebitis Phlebitis is an acute inflammation of a vein directly linked to the presence of any vascular access device (Jackson 1998). The first indication of potential problems is often when the patient reports pain. If treated early enough, the symptoms can resolve without further intervention. Reduction in phlebitis rates and reduction in the severity of injuries have been shown in anaesthetised patients where a dedicated cannula is used solely for post-operative purposes (Panadero et al 2002) . Many clinical areas now consider it good practice to use a phlebitis scale (Table 5) .
Phlebitis is the most common complication of IV infusion therapy, and studies demonstrate that 20-80 per cent of patients receiving peripheral IV therapy develop phlebitis (Panadero et al 2002) . Phlebitis can be further classified into mechanical, chemical and infective phlebitis, depending on the cause of the problem. Mechanical is predominantly due to cannula problems which cause trauma to the intimal wall of the vessel. This could occur on insertion or be caused by displacement of the catheter following manipulation. Chemical phlebitis is a consequence of the compositions 
Strategies to reduce the risk of anaphylaxis
Ensure that a detailed patient history is taken and full physical examination performed.
Consider the administration route and the rate of the medicine and/or fluid.
Identify patients with known allergies who may have had or may have an anaphylactic reaction.
Ensure good knowledge of the medicine, as some cross-react and are contraindicated if there is a known history of anaphylaxis.
Time out 7
Identify which medications used in your clinical area could present the greatest risks to patients. Identify the steps you would take if a patient had phlebitis, infiltration or extravasation.
and tenderness. The Intravenous Nurses Society (2000) has devised an infiltration scale (Table 6 ). Extravasation Extravasation is the leakage of IV drugs from the vein into the surrounding tissues (Jones and Stanley 1997) . It tends to relate to the leakage of vesicant drugs, meaning the potential for injury is increased. Moreno de Vega et al (2002) report that the most destructive medications are those that contain vinca alkaloids. Many substances which are used regularly can also cause damage and should be used with caution. Examples include sodium bicarbonate, potassium chloride, 10% glucose and erythromycin (CP Pharmaceuticals Ltd 1999) . Chemotherapy also presents a high risk to patients and only qualified staff should administer this therapy following training on administration, side effects and action for specific medications.
Local policies for treating extravasations vary, often according to the specialty, age group of the patient and the medications being used. Common treatments can vary from wound exposure, occlusive dressings, infiltration with hyaluronidase and saline, to plastic surgery. Local extravasation kits may also be available to ensure quick action where necessary. It is essential that nurses protect themselves by documenting each stage of an extravasation and the action taken. This is to ensure that, should litigation occur due and concentration of the infusate, in particular infusates with extremes of Ph or osmolality, resulting in damage to the endothelium of the vessel wall (Philpot and Griffiths 2003) . Infective phlebitis occurs when the tip of the cannula is infected (usually confirmed when blood cultures show the same microbiology as the tip that is sent for culture).
Treatment for phlebitis is usually heat and analgesia (Philpot and Griffiths 2003) ; however, the use of transdermal anti-inflammatory gel is reported to be beneficial (Cokmez et al 2003 Patients who have had repeated IV infusion and or injections (these may thrombose vessels and limit the number of accessible veins). This could also apply to patients with substance misuse problems.
(CP Pharmaceuticals Ltd 1999)
BOX 3
Patients most at risk of phlebitis, infiltration and extravasation to patient injury, the sequence of events is clear. In the neonatal specialty, one of the at risk groups, the prevalence is reported to be 38 per 1,000 (Wilkins and Emmerson 2004 relating to peripheral IV therapy, while also maintaining and meeting professional requirements (NMC 2004a) . It is essential that staff are appropriately trained and are knowledgeable of the medicines in use in their practice. This is currently addressed as part of post-registration education and training. To allow skilled staff to transfer skills across specialties requires some standardisation of educational outcomes, which would have benefits for individuals and organisations (NES 2004) . This has implications for undergraduate education and relates to the future role of nurse prescribing. Consideration should be given to medical staff and their role in prescribing, and whether shared education is of benefit to reduce any associated risks.
Manufacturers can reduce risks associated with peripheral IV therapy by using consistent, standardised and clear labelling. This article has identified and suggested strategies to reduce risks in peripheral IV practice. Adhering to these recommendations will result in safer patient care and practice NS Infuse the medication carefully and as per instructions.
Only specially trained personnel should administer specific groups of medication, for example, chemotherapy.
Identify 'at risk' patients and promote frequent checks.
Document checks and report all changes, even those that are minor.
Ensure the cannula is secured correctly.
Check local policy guidance on treating phlebitis, infiltration and extravasation injuries.
Conclusion
Ensuring standards are reviewed and adhered to is crucial for safe evidence-based practice learning zone intravenous drug administration 
